BioNTech SE (BNTX) Tops Q1 EPS by 27c

BioNTech SE (NASDAQ: BNTX) reported Q1 EPS of (EUR1.73), EUR0.27 better than the analyst estimate of (EUR2.00). Revenue for the quarter came in at EUR182.8 million versus the consensus estimate of EUR204.08 million.

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.

You May Also Be Interested In

• Bank of America (BAC) Tops Q2 EPS by 9c, Beats on Revenue
• United Airlines (UAL) call put ratio 1 call to 1.2 puts into quarter results
• Bernstein SocGen Group Starts Asymchem Laboratories Tianjin Co Ltd (002821:CH) at Outperform